• Verification code
  • Optimal Prices
    Buying products on this site guarantees the best price
  • Flexible Batches
    Flexible batch size to meet different needs of global customers
  • Prompt Delivery
    Warehouses in multiple cities to ensure timely delivery
  • Quality Assurance
    Strict process parameter control to ensure product quality
  • One-to-one Customization
    One-to-one custom synthesis for special structural needs

Cerdulatinib-[13C4]

General Information
Catalog: BLP-000883
Molecular Formula: C16[13C]4H27N7O3S
Molecular Weight: 449.54
Chemical Structure
Cerdulatinib-[13C4]
Description Cerdulatinib-[13C4] is the labelled analogue of Cerdulatinib. Cerdulatinib, also known as PRT2070 and PRT062070, is a novel, oral, dual spleen tyrosine kinase (Syk) and janus kinase (JAK) inhibitor. Cerdulatinib preferentially inhibited JAK1 and JAK3 dependent cytokine mediated signaling and functional responses in various cell types.
Synonyms [13C4]-Cerdulatinib
IUPAC Name 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl-2,3,5,6-13C4)phenyl)amino)pyrimidine-5-carboxamide
Related CAS 1198300-79-6 (unlabelled)
Appearance Beige Solid

Interested in our Service & Products?
Need detailed information?

USA
  • International: 1-631-504-6093
  • US & Canada (Toll free): 1-844-BOC(262)-0123
  • 45-16 Ramsey Road, Shirley, NY 11967, USA
  • Email: info@bocsci.com
  • Fax: 1-631-614-7828
UK
  • 44-20-3286-1088
  • 85 Great Portland Street, London, W1W 7LT
  • Email: info@bocsci.com
Copyright © 2025 BOC Sciences. All Rights Reserved.
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x